It has been previously demonstrated that Src family kinases (SFKs), which include cSrc, Yes, Fyn, Lyn and Yes etc. are often de-regulated in multiple cancers, including prostate cancer, and cause aberrant regulation of many cellular processes involved in tumor progression and metastases [27-32]. This evidence concerns the gene YES1 and cancer.